(90 days)
No
The device description details a standard pulse oximetry technology using light absorption and a microprocessor for calculation, with no mention of AI or ML algorithms.
No.
The device is indicated for monitoring and measurement, not for treatment or therapy.
Yes
The device is described as monitoring functional oxygen saturation of arterial hemoglobin (SpO2) and pulse rate (PR), which is a measurement used to assess a patient's physiological state. While it doesn't provide a diagnosis, it provides critical information for healthcare professionals to make diagnostic decisions.
No
The device description explicitly states that the device consists of physical components such as connectors, cables, a patient sensor terminal, light emitting diodes, and a light detector, which are hardware.
No, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostic devices are used to examine specimens taken from the human body, such as blood, urine, or tissue, outside of the body. They are used to diagnose diseases or other conditions.
- Device Function: The description clearly states that the SpO2 sensors are used for continuous non-invasive monitoring of oxygen saturation and pulse rate by attaching to the patient's finger. This is done on the patient's body, not on a specimen taken from the body.
- Mechanism: The device works by shining light through tissue and measuring light absorption, which is a physical measurement taken directly from the patient. It does not analyze a biological sample.
Therefore, based on the provided information, the Reusable and Disposable SpO2 Sensors are not an In Vitro Diagnostic device. They are a medical device used for physiological monitoring.
N/A
Intended Use / Indications for Use
The Reusable and Disposable SPO2 Sensors are indicated for continuous non-invasive monitoring of functional oxygen saturation of arterial hemoglobin (SpO2) and pulse rate (PR) for adult patients weighing greater than 40kg. The sensors are intended to be used in hospital settings where patient care is offered by qualified healthcare personnel.
Product codes
DQA
Device Description
The proposed device, Reusable and Disposable SpO2 sensors are the accessory of the patient monitors, which are intended for continuous monitoring of functional arterial oxygen saturation and pulse rate in non-invasive way with legally marketed devices.
The sensor shall be connected to its corresponding monitor (Nellcor, N-600x cleared in K060576), and it is used to attach the patient's finger and measure oxygenation of blood from detecting the infrared-light and red-light absorption characteristics of deoxygenated hemoglobin and oxygenated hemoglobin. The sensor is connected to a data acquisition system which is used to calculate and display oxygen saturation values and heart rate conditions.
The Reusable and Disposable SpO2 sensors consist of compatible connectors, cable, and patient sensor terminal. And the optical components of sensor are designed to a light emitting diode and a light detector. Red and Infrared lights are shone through the terminal tissues. Then parts of the emitting lights are absorbed by blood and tissues. The light absorbed by the blood varies with the oxygen saturation of haemoglobin. The light detector detects the light volume transmitted through the tissues on the basis of blood pulse, then the microprocessor calculates a value for the oxygen saturation by measuring the absorbance of the wave peak and the wave trough. The saturation values are determined by the percentage ratio of the oxygenated hemoglobin (HbO2) to the total amount of hemoglobin (Hb).
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
patient's finger
Indicated Patient Age Range
adult patients weighing greater than 40kg.
Intended User / Care Setting
hospital settings where patient care is offered by qualified healthcare personnel.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
The following performance data of Reusable and Disposable SpO2 Sensors were provided in support of the substantial equivalence determination:
Biocompatibility testing: The biocompatibility evaluation for the Reusable and Disposable SpO2 Sensors were conducted in accordance with the International Standard ISO 10993-1 "Biological Evaluation of Medical Devices - Part 1: Evaluation and Testing within a Risk Management Process," as recognized by FDA. The terminal sensor and cable are considered to be contacted with patient's intact skin for duration of less than 24 hours. The biocompatibility testing includes the following: Cytotoxicity, Skin Sensitization, Skin Irritation.
Electrical safety and electromagnetic compatibility (EMC):
Electrical safety and EMC testing were conducted, and the results show that the proposed device complies with the following standards:
- IEC 60601-1: 2005 + CORR. 1 (2006) + CORR. 2 (2007) + AM1 (2012) Medical electrical equipment - Part 1: General requirements for basic safety and essential performance for safety
- IEC 60601-1-2: 2014 Medical electrical equipment - Part 1-2: General requirements for basic safety and essential performance - Collateral Standard: Electromagnetic disturbances - Requirements and tests standard for EMC
- ISO 80601-2-61: 2017 + COR1:2018 Medical electrical equipment - Part 2-61: Particular requirements for basic safety and essential performance of Pulse Oximeter Equipment standard for performance effectiveness
Clinical study: Clinical studies were conducted to verify the accuracy of proposed device. The clinical studies were conducted per following standards:
- ISO 80601-2-61: 2017 Medical Electrical Equipment Part 2-61: Particular Requirements for Basic Safety and Essential Performance of Pulse Oximeter Equipment.
- Pulse Oximeters-Premarket Notification Submissions: Guidance for Industry and Food and Drug Administration Staff Clinical testing has been performed under an approved protocol with subject informed consent.
Clinical hypoxia test results were obtained in human adult volunteers to validate the accuracy of Reusable and Disposable SpO2 Sensors versus arterial oxygen saturation (SaOz) as determined by CO-oximeter. Clinical test results support device accuracy claims for the specified saturation range. The SpO2 accuracy has been validated in human studies against arterial blood sample reference measured with a CO-oximeter. Pulse oximeter measurements are statistically distributed, the volunteer population in the studies composed of healthy men and women from age 21 to 50, with variations of skin pigmentations and per FDA's guidance for Pulse Oximeters, three darkly pigmented subjects are included in the clinical study.
Key Metrics
SPO2 Accuracy: ±3% (70-100%)
Pulse Rate Accuracy: ±3(30-250bpm)
Predicate Device(s)
Reference Device(s)
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 870.2700 Oximeter.
(a)
Identification. An oximeter is a device used to transmit radiation at a known wavelength(s) through blood and to measure the blood oxygen saturation based on the amount of reflected or scattered radiation. It may be used alone or in conjunction with a fiberoptic oximeter catheter.(b)
Classification. Class II (performance standards).
0
Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which consists of the letters "FDA" in a blue square, followed by the words "U.S. FOOD & DRUG" in blue, with the word "ADMINISTRATION" underneath.
August 19, 2020
Xinkang Medical Instrument Co. Ltd. % James Tsai Consultant Shenzhen Joyantech Consulting Co., Ltd. 1713A, 17th Floor, Block A, Zhongguan Times Square, Nanshan District Shenzhen, Guangdong 518000 China
Re: K201360
Trade/Device Name: Reusable and Disposable SpO2 Sensors Regulation Number: 21 CFR 870.2700 Regulation Name: Oximeter Regulatory Class: Class II Product Code: DQA Dated: March 18, 2020 Received: May 21, 2020
Dear James Tsai:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
1
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely.
Todd Courtney Assistant Director DHT1C: Division of ENT, Sleep Disordered Breathing, Respiratory and Anesthesia Devices OHT1: Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K201360
Device Name
Reusable and Disposable SPO2 Sensors
Indications for Use (Describe)
The Reusable and Disposable SPO2 Sensors are indicated for continuous non-invasive monitoring of functional oxygen saturation of arterial hemoglobin (SpO2) and pulse rate (PR) for adult patients weighing greater than 40kg. The sensors are intended to be used in hospital settings where patient care is offered by qualified healthcare personnel.
| Type of Use (Select one or both, as applicable) | |
|---|---|
| ☑ Prescription Use (Part 21 CFR 801 Subpart D) | ☐ Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
510(k) Summary
K201360
This summary of 510(K) safety and effectiveness information is submitted as required by requirements of SMDA and 21 CFR §807.92.
1 Administrative Information
| Date of Summary prepared | July 13, 2020 |
|---|---|
| Manufacturer information | Company: Xinkang Medical Instrument Co., Ltd |
| Company address: | |
| 2 Floor, Puhua Science and Technology Park, | |
| Tongsheng Community Dalang Street, Longhua | |
| District, 518109 Shenzhen, People's Republic of | |
| China | |
| Contact person: Xu Changsheng | |
| Phone: +86-755-23776681 | |
| Fax: +86-755-23776861 | |
| E-mail: 751857289@qq.com | |
| Submission Correspondent | Shenzhen Joyantech Consulting Co., Ltd. |
| Address: 1713A, 17th Floor, Block A, | |
| Zhongguan Times Square, Nanshan District, | |
| Shenzhen | |
| Contact person: James Tsai | |
| E-Mail: james_tsai@cefda.com | |
| Establishment registration number | |
| 2 Device Information | |
| Type of 510(k) submission: | Traditional |
| Trade Name: | Reusable and Disposable SpO2 Sensors |
| Classification name: | Oximeter |
| Review Panel: | Cardiovascular devices |
| Product Code: | DQA |
| Device Class: | II |
4
Regulation Number: | 870.2700
3 Predicate Device Information
Unimed Medical Supplies, Inc. Sponsor: Unimed Reusable and Disposable SpO₂ Sensors Device: K142832 510(K) Number: Review Panel: Cardiovascular devices DQA Product Code: Device Class: ll 870.2700 Regulation Number:
4 Device Descriptions
The proposed device, Reusable and Disposable SpO2 sensors are the accessory of the patient monitors, which are intended for continuous monitoring of functional arterial oxygen saturation and pulse rate in non-invasive way with legally marketed devices.
The sensor shall be connected to its corresponding monitor (Nellcor, N-600x cleared in K060576), and it is used to attach the patient's finger and measure oxygenation of blood from detecting the infrared-light and red-light absorption characteristics of deoxygenated hemoglobin and oxygenated hemoglobin. The sensor is connected to a data acquisition system which is used to calculate and display oxygen saturation values and heart rate conditions.
The Reusable and Disposable SpO2 sensors consist of compatible connectors, cable, and patient sensor terminal. And the optical components of sensor are designed to a light emitting diode and a light detector. Red and Infrared lights are shone through the terminal tissues. Then parts of the emitting lights are absorbed by blood and tissues. The light absorbed by the blood varies with the oxygen saturation of haemoglobin. The light detector detects the light volume transmitted through the tissues on the basis of blood pulse, then the microprocessor calculates a value for the oxygen saturation by measuring the absorbance of the wave peak and the wave trough. The saturation values are determined by the percentage ratio of the oxygenated hemoglobin (HbO2) to the total amount of hemoglobin (Hb).
5 Intended Use/ Indications for Use
The Reusable and Disposable SpO2 Sensors are indicated for continuous noninvasive monitoring of functional oxygen saturation of arterial hemoglobin (SpOz) and pulse rate (PR) for adult patients weighing greater than 40kg. The sensors are intended to be used in hospital settings where patient care is offered by qualified healthcare personnel.
6 Comparison to predicate device
5
| Comparison
| item | Proposed Device | Predicate Device (K142832) |
|---|---|---|
| Product name | Reusable and | |
| disposable SpO2 sensor | Unimed Reusable and Disposable | |
| SpO2 Sensors | ||
| Model | Adult/reusable: XSAE3 | |
| Adult/disposable: XDAN | Adult/reusable: U403S-01 | |
| Adult/disposable: U503-01 | ||
| Product Code | DQA | DQA |
| Regulation | ||
| Number | 870.2700 | 870.2700 |
| Classification | II | II |
| Intended | ||
| use & | ||
| Indication | ||
| s for Use | The Reusable and Disposable | |
| SpO2 Sensors are indicated for | ||
| continuous non-invasive monitoring | ||
| of functional oxygen saturation of | ||
| arterial hemoglobin (SpO2) and | ||
| pulse rate (PR) for adult patients | ||
| weighing greater than 40kg. The | ||
| sensors are intended to be used in | ||
| hospital settings where patient care | ||
| is offered by qualified healthcare | ||
| personnel. | Unimed Disposable and Reusable | |
| SpO2 Sensors are indicated for | ||
| continuous non-invasive monitoring of | ||
| functional oxygen saturation of arterial | ||
| hemoglobin (SpO2) and pulse rate | ||
| (PR) for adult patients weighing | ||
| greater than 40kg, pediatric patients | ||
| weighing 10-50 kg, and neonatal | ||
| patients weighing no less than 3 Kg. | ||
| Measurement | ||
| Method | 2-wavelength Relative | |
| Optical Absorption | 2-wavelength Relative | |
| Optical Absorption | ||
| Light | ||
| Emitting | Red: 660nm±3nm | |
| Infrared: 880-950nm | Red: 660-666nm | |
| Infrared: 880-950nm | ||
| Signal | ||
| Detection | ||
| Method | Photodetector | Photodetector |
| SPO2 | ||
| Accuracy | ±3% (70-100%) | ±3% (70-100%) |
| Pulse | ||
| Rate | ||
| Accuracy | ±3(30-250bpm) | ±3 (30-250bpm) |
| Applied | ||
| population | Adult (≥40Kg) | Adult (≥40Kg) |
| Measurement | ||
| part | Fingers | Fingers |
| Distal | ||
| connector | ||
| design | Soft tip, non-woven | Soft tip, textile adhesive |
| Compatible | ||
| monitor | Nellcor | Nellcor |
| Sterile | No | No |
| Material | Silicone, Non-woven | Silicone, 3M |
| Biocompatibility | Cytotoxicity | |
| Irritation | ||
| Sensitization | Cytotoxicity | |
| Irritation | ||
| Sensitization | ||
| Electrical | ||
| Performance | ||
| and Safety | IEC60601-1,IEC60601-1-2, | |
| ISO80601-2-61,ISO10993- | ||
| 5/10 | IEC60601-1,IEC60601-1-2, | |
| ISO80601-2-61,ISO10993- | ||
| 5/10 |
6
The proposed device and the predicate device have the same intended use and similar technological characteristics; they both measure SpO2 values for the patients.
7 Performance data
The following performance data of Reusable and Disposable SpO2 Sensors were provided in support of the substantial equivalence determination:
Biocompatibility testing
The biocompatibility evaluation for the Reusable and Disposable SpO2 Sensors were conducted in accordance with the International Standard ISO 10993-1 "Biological Evaluation of Medical Devices - Part 1: Evaluation and Testing within a Risk Management Process," as recognized by FDA. The terminal sensor and cable are considered to be contacted with patient's intact skin for duration of less than 24 hours. The biocompatibility testing includes the following:
- Cytotoxicity .
- Skin Sensitization ●
- Skin Irritation .
Electrical safety and electromagnetic compatibility (EMC)
Electrical safety and EMC testing were conducted, and the results show that the proposed device complies with the following standards:
- IEC 60601-1: 2005 + CORR. 1 (2006) + CORR. 2 (2007) + AM1 (2012) Medical . electrical equipment - Part 1: General requirements for basic safety and essential performance for safety
- . IEC 60601-1-2: 2014 Medical electrical equipment - Part 1-2: General requirements for basic safety and essential performance - Collateral Standard: Electromagnetic disturbances - Requirements and tests standard for EMC
- . ISO 80601-2-61: 2017 + COR1:2018 Medical electrical equipment - Part 2-61: Particular requirements for basic safety and essential performance of Pulse Oximeter Equipment standard for performance effectiveness
Clinical study
Clinical studies were conducted to verify the accuracy of proposed device. The clinical studies were conducted per following standards:
- ISO 80601-2-61: 2017 Medical Electrical Equipment Part 2-61: Particular Requirements for Basic Safety and Essential Performance of Pulse Oximeter Equipment.
- · Pulse Oximeters-Premarket Notification Submissions: Guidance for Industry and Food and Drug Administration Staff Clinical testing has been performed under an approved protocol with subject informed consent.
7
Clinical hypoxia test results were obtained in human adult volunteers to validate the accuracy of Reusable and Disposable SpO2 Sensors versus arterial oxygen saturation (SaOz) as determined by CO-oximeter. Clinical test results support device accuracy claims for the specified saturation range. The SpO2 accuracy has been validated in human studies against arterial blood sample reference measured with a CO-oximeter. Pulse oximeter measurements are statistically distributed, the volunteer population in the studies composed of healthy men and women from age 21 to 50, with variations of skin pigmentations and per FDA's guidance for Pulse Oximeters, three darkly pigmented subjects are included in the clinical study.
Summary
Based on the non-clinical performance and clinical data as documented in the device development, the proposed device has a safety and effectiveness profile that is similar to the predicate device.
8 Conclusions
Based on device comparison information and performance data, the proposed device has the same intended use as the predicate device, and the differences in technological characteristics does not raise different questions of safety and effectiveness. Therefore, the proposed device is substantially equivalent to the predicate device.